Halozyme Therapeutics (HALO) came out with quarterly earnings of $0.79 per share, beating the Zacks Consensus Estimate of $0.69 per share. This compares to earnings of $0.47 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 14.49%. A quarter ago, it was expected that this biopharmaceutical company would post earnings of $0.82 per share when it actually produced earnings of $0.82, delivering no surprise.Over the last four quarter ...